目的:观察不同培养液及不同培养时期等因素对体外培养人脑胶质瘤细胞CD133阳性(CD133^+)细胞比率的影响。方法:用干细胞培养液(含EGF、FGF-2、B27)培养6例原代胶质瘤细胞和3例对照细胞株,用流式细胞仪检测培养第0、3、7、28、60、90和120天时不同细胞的CD133^+细胞比率;免疫组化观察胶质瘤干细胞的多向分化能力;用血清、无血清和干细胞3种培养液分别培养2例长期培养的胶质瘤SHG62、SHG66细胞系以及对照的U87和U251细胞株,观察胶质瘤中CD133^+细胞在不同培养液中的相互转换。结果:胶质瘤CD133^+细胞比率随培养时间推移明显下降(P〈0.05),1周左右均降至〈1%的低水平,而细胞株则比较稳定;干细胞培养液培养的细胞中CD133^+细胞比率明显高于血清和无血清培养液培养(P〈0.01);此外,胶质瘤细胞中的干细胞具有多向分化的能力,并且可以在干细胞和血清培养液中互相转换。结论:原代胶质瘤体外培养过程中CD133^+细胞比率逐渐下降,而干细胞培养液能明显提高CD133^+细胞比率,并且CD133^+细胞可以在不同培养液中相互转换。说明生长环境对干细胞比率影响较大,提示可能存在尚未明了的影响干细胞生长分化的相关因子。
Aim : To find the dynamic changes of CD133^+(CD133 positively expressed) cells in primary culture and also in different mediums. Methods: Six primary malignant glioma cells and 3 glioma cell strains were cultured in stem cell medium (supplemented with EGF, FGF-2 and B27), then their ratios of CD 133^+ cells were checked with flowcytometry on day 0,3,7,28,60,90,120 respectively. Multiple differentiations of stem cells were proved by immunocytochemistry. Then changes of the ratios of CD133^+ cells of SHG62, SHG66 (long-term cultured in our laboratory) and U87, U251 cell strains cultured in medium with or without serum and stem cell medium were observed. Results: The ratios of CD133^+ cells in primary gliomas decreased evidently with time(P〈0.05), while cell strains remained stationary levels. The ratio of CD 133^+ cells was higher in stem cell medium than in serum-supplemented medium and serum-free medium. Conclusion: The ratios of CD133^+ cells dropped with time in primary gliomas, and stem cell mediums were favored for CD133^+ cells. And the cells could be switched successfully between serum-free medium and stem cell medium, which hints that there might be some undiscovered factors for stem cells thriving.